Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study

by Jon-David Schwalm, MD, MSc, FRCP, Tara McCready, PhD, MBA, Scott A. Lear, PhD, Pablo Lamelas, MD, MSc, Len Garis, Hadi Musa, MHK, Kaitey Vincent, BA, Shofiqul Islam, PhD, Amir Attaran, DPhil, Martin McKee, CBE, MD, DSc, MSc, FRCP, FRCPE, FRCPI, FFPH, FMedSci, Salim Yusuf, MD, DPHIL, MRCP
Published 2021-03-01

Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study

by MyLinh Duong, MBBS, Shofiqul Islam, PhD, Sumathy Rangarajan, MSc, Darryl Leong, PhD, Om Kurmi, PhD, Koon Teo, ProfMB, Kieran Killian, PhD, Gilles Dagenais, ProfMD, Scott Lear, ProfPhD, Andreas Wielgosz, ProfMD, Sanjeev Nair, ProfMD, Viswanathan Mohan, MD, Prem Mony, MD, Rajeev Gupta, ProfMD, Rajesh Kumar, ProfMD, Omar Rahman, ProfDSc, Khalid Yusoff, ProfMBBS, Johannes Lodewykus du Plessis, ProfPhD, Ehimario U Igumbor, PhD, Jephat Chifamba, DPhil, Wei Li, ProfPhD, Yin Lu, PhD, Fumin Zhi, BSc, Ruohua Yan, MSc, Romaina Iqbal, PhD, Noorhassim Ismail, ProfMD, Katarzyna Zatonska, MD, Kubilay Karsidag, ProfMD, Annika Rosengren, ProfMD, Ahmad Bahonar, MD, Afazalhussein Yusufali, MD, Pablo M Lamelas, MD, Alvaro Avezum, ProfMD, Patricio Lopez-Jaramillo, ProfMD, Fernando Lanas, ProfMD, Paul M O'Byrne, ProfMB, Salim Yusuf, ProfDPhil
Published 2019-05-01